Volume 4, Issue 5 | May 2026
|
|
|
|
|
|
|
|
|
|
|
Advancing biopharma innovation
|
|
|
|
Access a selection of Mayo Clinic-developed biopharma innovations available for licensing and strategic collaboration. Built on a foundation of clinical insight and scientific excellence, these technologies are designed to help collaborators accelerate development, navigate complex challenges and deliver meaningful impact for patients around the world.
|
|
|
|
|
|
Cure Innovation Index: Most innovative institutions
Mayo Clinic ranked #2 among U.S. institutes and centers in the 2026 Cure Innovation Index, a new national benchmark assessing how effectively biomedical institutions translate discovery into real-world healthcare impact. Read more...
|
|
|
|
|
|
NAI announces 2025 top 60 worldwide non-profit institutions and government agencies
Mayo Clinic ranked No. 13 worldwide, with 106 patents. The recognition highlights organizations advancing discoveries from research into protected innovations with potential societal and economic impact. Read more...
|
|
|
|
|
A new AI tool could transform how we diagnose genetic diseases
Researchers at Mayo Clinic and Goodfire, a San Francisco research startup, have used an AI model to predict which genetic mutations cause disease and to explain why offering a new approach to diagnosing and studying genetic disorders at scale. Read more...
|
|
|
|
Portfolio company and collaboration updates
|
|
|
|
|
|
|
|
|
|
|
|
|
COLLABORATOR SNAPSHOT
Anumana
RECENT PROGRESS
BUSINESS DEVELOPMENT CONNECTION
• Enables collaboration opportunities in AI diagnostics and digital health integration
|
|
|
|
|
|
|
|
|
|
Nucleus RadioPharma secured $50M in financing from OrbiMed to expand radiopharmaceutical manufacturing capacity, supporting growing demand for targeted therapies.
|
|
|
|
|
|
Onymos announced a collaboration to advance AI-driven intelligent document processing for healthcare workflows.
|
|
|
|
|
|
INBRAIN Neuroelectronics completed enrollment in the first-in-human study of its graphene-based neural interface for brain decoding and mapping.
|
|
|
|
|
|
Sana Biotechnology launched a strategic collaboration to improve care in type 1 diabetes and accelerate development of SC451.
|
|
|
|
|
|
Joy Metrics (formerly SE Healthcare) entered a new agreement to advance predictive workforce intelligence focused on clinician fatigue risk.
|
|
|
|
|
|
Mesoblast acquired CAR platform technology to enhance precision and performance of its cell therapy pipeline.
|
|
|
|
|
|
Pendulum Therapeutics expanded its clinical collaboration to advance microbiome research in women’s health and dermatology.
|
|
|
|
|
|
The Contract Network will be acquired by WCG, enhancing AI-driven site enablement and accelerating clinical trial startup through its ClinSphere platform.
|
|
|
|
|
|
Techcyte announced a $15 million capital raise led by Van Tuyl Companies to support growth and path to profitability.
|
|
|
|
|
|
Mayo Clinic: Research and care advancements
|
|
|
|
AI helps specialists detect pancreatic cancer up to three years earlier
Mayo Clinic Magazine
A Mayo Clinic-developed AI model can identify early signs of pancreatic cancer on routine CT scans up to three years before clinical diagnosis by detecting subtle tissue changes not visible to clinicians. In a large validation study, the model identified 73% of prediagnostic cases, significantly improving early detection compared to standard review. Read more...
|
|
|
|
|
|
|
Study finds Alzheimer’s changes begin decades before symptoms
|
|
|
|
Researcher awarded Breakthrough Prize for ALS-dementia discovery
|
|
|
|
New awards aim to accelerate regenerative therapies in Minnesota
|
|
|
|
|
|
|
Experimental nanotherapy crosses blood-brain barrier in glioblastoma study
|
|
|
|
Remote monitoring may detect early complications in lung transplant patients
|
|
|
|
Advancing care for ALS and FTD through new discoveries
|
|
|
|
|
|
AROUND MAYO CLINIC
What staff are talking about
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- MedTech World | May 11-13 | West Palm Beach, FL
- ASGCT | May 11-15 | Boston, MA
- ISPOR 2026 | May 17-20 | Philadelphia, PA
- McDermott HealthEx | May 20-21 | Nashville, TN
- Medtech MVP | June 1-2 | Minneapolis, MN
- AI Research Summit | June 4-5 | Rochester, MN (+ virtual option)
- Mayo Clinic Cardiology & Radiology Innovation Summit | June 11 | Rochester, MN
- Quantum Today, Healthcare Tomorrow | June 11 | Jacksonville, FL
- BIO International Convention | June 22-25 | San Diego, CA
- LSI Asia | June 30-July 2 | Singapore
- Tomorrow x Now | August 27 | Jacksonville, FL
|
UPCOMING MAYO CLINIC-HOSTED SUMMITS
|
|
The AI Research Summit will bring together researchers and leaders to explore AI advancements in healthcare, share emerging methods and discover new collaborations. Learn more
...
|
|
|
|
|
|
|
Mayo Clinic portfolio company Nucleus RadioPharma celebrated the grand opening of its new radiopharmaceutical manufacturing facility in Rochester, Minnesota, housed within Destination Medical Center (DMC)'s Discovery Square building.
Backed by a recent $50M financing round led by OrbiMed to support expanded manufacturing capacity across its Rochester operations and planned Philadelphia facility, the company continues to scale its capabilities.
Mayo Clinic Business Development staffers Janani Reisenauer, MD, and Bharath Wootla joined Mayo Clinic nuclear medicine specialist
Geoff Johnson, MD, PhD, alongside Minnesota Governor Tim Walz and Rochester Mayor Kim Norton ahead of the grand opening.
|
|
|
|
|
|
Geof brings a unique blend of relevant experience spanning biopharma R&D, startup innovation and strategic collaborations. To learn more about opportunities with BioLabs Rochester, contact Geof at hannigan.geoffrey@mayo.edu, or attend an upcoming information session:
|
|
|
|
MAYO CLINIC BUSINESS DEVELOPMENT | OPEN POSITIONS:
|
|
|
|
|
|
|
|
|
|
|
|
About Business Development
|
Business Development is Mayo Clinic’s front door to business – from technology commercialization to strategic collaborations – catalyzing innovation to shape the future of healthcare for the benefit of patients.
The department bridges the gaps between industry and commercial groups to produce meaningful, effective changes in transforming health and medicine.
|
|
|
|
|
|
|
|
|
